MANKIND

Mankind Pharma LimitedNSE
₹2,579.5+13.70 (+0.53%)

Market Closed · NSE · INR

Open

₹2,579.8

High

₹2,588.2

Low

₹2,559.9

Prev Close

₹2,565.8

52-Week Range85% from low
₹1,927.4
₹2,696.5

Market Cap

₹1.06 L Cr

Large Cap

P/E (TTM)

55.36

EPS

₹46.35

Div Yield

0.04%

P/B Ratio

6.43

ROE

11.7%

Key Metrics

Forward P/E36.01
Book Value₹401
Debt/Equity0.38×
Revenue Growth11.8%
Profit Margin16.25%
Operating Margin25.34%
Volume5.87 L
Avg Volume (20d)4.93 L
Delivery %41.59%
Trades32,348

Analyst Ratings(19 analysts)

Buy

Target Price

₹2,668

+3.4% upside

Strong Buy9
Buy5
Hold1
Sell1
Strong Sell3
Low: ₹2,057Median: ₹2,734High: ₹3,100

Current price: ₹2,580

Upcoming Events

Earnings Date
30 Jul 2026

What If I Had Invested?

Chart data not available for this range

AI Analysis

Get AI-powered sentiment analysis, strengths, risks, and outlook for this stock.

AI Technical Analysis

Buy/sell zones with live web research

Get AI-generated buy zones, sell targets, stop-loss levels and a technical narrative — powered by AI with live web search for the latest news and analyst moves.

Patterns are measured on real price data, then AI-validated. Pattern detection is free when nothing clean is found.

About

HealthcareDrug Manufacturers - Specialty & Generic

Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products in India and internationally. The company develops pharmaceuticals for acute and chronic therapeutics in the areas of anti-infective, cardiovascular, gastrointestinal, gynaecology,...

mankindpharma.com20,451 employees

Technical Indicators

Loading sector benchmark…

Quality scores

Valuation bands

Intrinsic value calculators

Peer Comparison

Dividend History

Recent: 1.00/share
08 Aug 20251.00
Loading events…

Recent Filings (NSE)

Raw NSE filings — full text + attachments. Tap any row for an AI summary that explains what it means for the stock.

Institutional Deals(NSE)

Source: NSE India. Block deals ≥5L shares or ≥₹10Cr. Bulk deals ≥0.5% of shares.

Governance Scorecard

AlphaView composite

Fund Actions

Loading fund activity…

News

News sourced from RSS feeds. Headlines link to original articles.

Disclaimer: This is AI-generated educational information, not investment advice. Stock data is delayed by up to 15 minutes. Past performance does not guarantee future results. Please consult a SEBI-registered investment advisor before making investment decisions.